Structure of Terfenadine
CAS No.: 50679-08-8
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Terfenadine is a potent open-channel blocker of hERG with a mean IC50 of 204 nM.
Synonyms: MDL-991; NSC 665802; Terfen
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 50679-08-8 |
Formula : | C32H41NO2 |
M.W : | 471.67 |
SMILES Code : | CC(C)(C1=CC=C(C(CCCN2CCC(C(C3=CC=CC=C3)(O)C4=CC=CC=C4)CC2)O)C=C1)C |
Synonyms : |
MDL-991; NSC 665802; Terfen
|
MDL No. : | MFCD00079622 |
InChI Key : | GUGOEEXESWIERI-UHFFFAOYSA-N |
Pubchem ID : | 5405 |
GHS Pictogram: |
![]() ![]() ![]() |
Signal Word: | Danger |
Hazard Statements: | H302-H361-H372-H410 |
Precautionary Statements: | P201-P264-P280-P301+P330+P331-P312 |
Class: | 9 |
UN#: | 3077 |
Packing Group: | Ⅲ |
Target |
|
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT01940393 | Urticaria | Phase 4 | Completed | - | Colombia ... More >> Medellin Medellin, Antioquia, Colombia Less << |
NCT02056743 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... More >> Clinical Trial Center of Chonbuk National University Hospital Jeonju, Jeollabuk-do, Korea, Republic of Less << |
NCT02966665 | Chronic Obstructive Pulmonary ... More >>Disease Pulmonary Artery Hypertension Heart Failure Hypertension Less << | Phase 1 | Recruiting | August 2020 | United States, Utah ... More >> George E Wahlen VA Medical Center Recruiting Salt Lake City, Utah, United States, 84132 Contact: Russell Richardson, Ph.D. 801-582-1565 r.richardson@hsc.utah.edu Contact: Ashley Nelson, MD 801-582-1565 ext 4127 ash.nelson@hsc.utah.edu Less << |
NCT02391688 | Drug Interaction | Phase 1 | Completed | - | Switzerland ... More >> Centre de Recherche Clinique, HUG, Rue Gabrielle Perret-Gentil 4 Genève, Switzerland, 1211 Less << |
NCT00637585 | Allergic Rhinitis | Phase 4 | Completed | - | United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less << |
NCT02171546 | Healthy | Phase 1 | Terminated | - | - |
NCT01683552 | ITCH | Phase 2 | Completed | - | Italy ... More >> Campus Bio-Medico of Rome University Roma, Italy, 00128 Less << |
NCT00783146 | Seasonal Allergic Rhinitis | Phase 4 | Completed | - | - |
NCT02551536 | Allergic Rhinitis | Phase 4 | Completed | - | - |
NCT00783211 | Seasonal Allergic Rhinitis | Phase 4 | Completed | - | - |
NCT03012763 | Pharmacokinetics ... More >> Magnetic Resonance Imaging Administration, Oral Less << | Phase 1 | Completed | - | - |
NCT01133470 | Healthy | Phase 1 | Completed | - | India ... More >> Veeda Clinical Research Pvt. Ltd., Ahmedabad, Gujrat, India, 380015 Less << |
NCT01586091 | Allergic Rhinitis | Phase 1 | Completed | - | Germany ... More >> University of Berlin Charité Berlin, Germany, 10117 Less << |
NCT01306721 | Rhinitis Seasonal | Phase 3 | Completed | - | Japan ... More >> Investigational Site Number 392002 Koganei-Shi, Japan Investigational Site Number 392003 Osaka-Shi, Japan Investigational Site Number 392001 Shinjuku-Ku, Japan Less << |
NCT03108274 | Drug Interaction Potentiation | Phase 1 | Completed | - | New Zealand ... More >> Auckland Clinical Studies Auckland, New Zealand, 1150 Less << |
NCT02175485 | Rhinitis Allergic | Phase 4 | Completed | - | Japan ... More >> Investigational Site Number 392-001 Shinjuku-ku, Japan Less << |
NCT00420082 | Seasonal Allergic Rhinitis | Phase 2 | Completed | - | Austria ... More >> Allergy Center Vienna West Vienna, Austria, A-1150 Less << |
NCT01133483 | Healthy | Phase 1 | Completed | - | India ... More >> Veeda Clinical Research Pvt. Ltd., Ahmedabad, Gujrat, India, 380015 Less << |
NCT00435461 | Rhinitis, Allergic, Seasonal | Phase 4 | Completed | - | United States, Texas ... More >> GSK Investigational Site Austin, Texas, United States, 78731 GSK Investigational Site Austin, Texas, United States, 78750 GSK Investigational Site Kerrville, Texas, United States, 78028 GSK Investigational Site New Braunfels, Texas, United States, 78130 GSK Investigational Site San Antonio, Texas, United States, 78205 GSK Investigational Site San Antonio, Texas, United States, 78229 Less << |
NCT00045955 | Asthma | Phase 3 | Completed | - | United States, New Jersey ... More >> Aventis Pharmaceutical Inc. Bridgewater, New Jersey, United States, 08807 Less << |
NCT00502775 | Rhinitis, Allergic, Seasonal | Phase 4 | Completed | - | - |
NCT00636870 | Allergic Rhinitis | Phase 4 | Completed | - | United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less << |
NCT00502775 | - | Completed | - | - | |
NCT00637611 | Seasonal Allergic Rhinitis | Phase 4 | Completed | - | United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less << |
NCT00435461 | - | Completed | - | - | |
NCT00637455 | Seasonal Allergic Rhinitis | Phase 4 | Completed | - | United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less << |
NCT00783133 | Seasonal Allergic Rhinitis | Phase 4 | Completed | - | - |
NCT00794768 | Seasonal Allergic Rhinitis | Phase 4 | Completed | - | - |
NCT00794248 | Seasonal Allergic Rhinitis | Phase 4 | Completed | - | - |
NCT00638118 | Allergic Rhinitis | Phase 4 | Completed | - | United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less << |
NCT01469234 | - | Completed | - | - | |
NCT01852318 | Uremic Pruritus | Phase 4 | Unknown | May 2015 | Taiwan ... More >> National Taiwan University (NTUH); NTUH Hsin-Chu Branch; NTUH Yun-Lin Branch; Cathay General hospital Not yet recruiting Taipei, Taiwan, 100; 300; 640; 280 Contact: Hsien-Yi Chiu, MD 0972654317 extra.owl0430@yahoo.com.tw Principal Investigator: Hsien-Yi Chiu, MD Less << |
NCT01526213 | Food-drug Interaction | Not Applicable | Completed | - | United States, North Carolina ... More >> North Carolina Clinical and Translational Research Center Chapel Hill, North Carolina, United States, 27599 Less << |
NCT02908750 | Non Small Cell Lung Cancer | Phase 1 | Active, not recruiting | March 13, 2019 | France ... More >> Research Site Rennes Cedex 9, France, 35033 Korea, Republic of Research Site Seongnam-si, Korea, Republic of, 13620 Research Site Seoul, Korea, Republic of, 05505 Spain Research Site Madrid, Spain, 28040 Research Site Madrid, Spain, 28046 Research Site Madrid, Spain, 28050 Research Site Sevilla, Spain, 41013 Less << |
NCT03183297 | Veisalgia | Phase 1 | Not yet recruiting | December 2017 | - |
NCT00044811 | Asthma | Phase 3 | Completed | - | United States, New Jersey ... More >> Aventis Pharmaceuticals Inc. Bridgewater, New Jersey, United States, 08807 Costa Rica Sanofi-Aventis Admnistrative Office Costa Rica, Costa Rica Guatemala Sanofi-Aventis Administrative Office Guatemala City, Guatemala Hungary Sanofi-Aventis Administrative Office Budapest, Hungary Mexico Sanofi-Aventis Administrative Office Mexico, Mexico Poland Sanofi-Aventis Administrative Office Warszawa, Poland Russian Federation Sanofi-Aventis Administrative Office Moscow, Russian Federation Less << |
NCT01469234 | Rhinitis | Phase 4 | Completed | - | - |
NCT00044824 | Asthma | Phase 3 | Completed | - | United States, New Jersey ... More >> Aventis Pharmaceuticals Inc. Bridgewater, New Jersey, United States, 08807 Costa Rica Sanofi-Aventis Admnistrative Office Costa Rica, Costa Rica Guatemala Sanofi-Aventis Administrative Office Guatemala City, Guatemala Hungary sanofi-aventis Hungaria Budapest, Hungary Mexico Sanofi-Aventis Administrative Office Mexico, Mexico Poland sanofi-aventis Poland Warszawa, Poland Russian Federation Sanofi-Aventis Aministrative Office Moscow, Russian Federation Less << |
NCT01526213 | - | Completed | - | - | |
NCT00261079 | Pruritus | Phase 4 | Completed | - | Korea, Republic of ... More >> Handok Seoul, Korea, Republic of Less << |
NCT00562120 | Allergic Rhinitis | Phase 2 | Completed | - | United States, Nebraska ... More >> Pfizer Investigational Site Omaha, Nebraska, United States, 68131 Less << |
NCT00637884 | Cat Induced Allergic Rhinitis | Phase 4 | Completed | - | - |
NCT00562120 | - | Completed | - | - | |
NCT00649376 | Healthy | Phase 1 | Completed | - | United States, West Virginia ... More >> Kendle International Inc. Morgantown, West Virginia, United States, 26505 Less << |
NCT00647985 | Healthy | Phase 1 | Completed | - | United States, West Virginia ... More >> Kendle International Inc. Morgantown, West Virginia, United States, 26505 Less << |
NCT00547768 | Allergy | Phase 4 | Completed | - | United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less << |
NCT00741897 | Rhinitis, Allergic, Perennial | Phase 4 | Completed | - | Philippines ... More >> Sanofi-aventis administrative office Makati City, Philippines Less << |
NCT00835276 | - | Completed | - | - | |
NCT00835640 | Healthy | Phase 1 | Completed | - | United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58102 Less << |
NCT01033396 | Allergic Rhinitis | Phase 2 | Completed | - | Canada, Ontario ... More >> Pfizer Investigational Site Kingston, Ontario, Canada, K7L 2V7 Less << |
NCT01066754 | Healthy | Phase 1 | Completed | - | Canada ... More >> Anapharm Inc., Sainte-Foy Quebec, Canada, G1V 2K8 Less << |
NCT01066767 | Healthy | Phase 1 | Completed | - | Canada ... More >> Anapharm Inc., Sainte-Foy Quebec, Canada, G1V 2K8 Less << |
NCT00835276 | Healthy | Phase 1 | Completed | - | United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58102 Less << |
NCT01172522 | - | Completed | - | - | |
NCT00835640 | - | Completed | - | - | |
NCT01888718 | Healthy | Phase 1 | Completed | - | India ... More >> Bioserve Clinical Research Private Limited Balanagar, Hyderabad, Andhra Pradesh, India, 500 037 Less << |
NCT01767272 | Healthy | Not Applicable | Completed | - | - |
NCT01172522 | Edema | Phase 2 | Completed | - | United States, New Jersey ... More >> TKL Research Paramus, New Jersey, United States, 07652 Less << |
NCT01298505 | Healthy | Phase 1 | Terminated(This study was stop... More >>ped due to lack of evidence for clinical efficacy.) Less << | - | Singapore ... More >> Pfizer Investigational Site Singapore, Singapore, 188770 Less << |
NCT03078777 | Hemodialysis | Phase 4 | Recruiting | August 2020 | Canada, Ontario ... More >> London Health Sciences Centre Recruiting London, Ontario, Canada, N6A5A5 Contact: Brad Urquhart, PhD 5196613756 Brad.Urquhart@schulich.uwo.ca Less << |
NCT02157558 | Drug Interactions | Phase 1 | Completed | - | United States, Texas ... More >> Lexicon Investigational Site Dallas, Texas, United States, 75247 Less << |
NCT03664882 | Rhinitis Seasonal | Phase 3 | Recruiting | February 2019 | Canada ... More >> Investigational Site Number Recruiting Canada, Canada Less << |
NCT00699894 | Postoperative Nausea and Vomit... More >>ing Less << | Not Applicable | Withdrawn(Logistical difficult... More >>ies running the study) Less << | - | United States, New York ... More >> Long Island Jewish Medical Center/Schneider's Children Hospital New Hyde Park, New York, United States, 11040 Less << |
NCT03425097 | Gastroesophageal Reflux | Phase 2 | Recruiting | May 2019 | United States, California ... More >> Silicon Valley Gastroenterology 2490 Hospital Dr. Suite 211 Recruiting Mountain View, California, United States, 94040 Contact: George Triadafilopoulos, MD 650-988-7530 vagt@stanford.edu Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.12mL 0.42mL 0.21mL |
10.60mL 2.12mL 1.06mL |
21.20mL 4.24mL 2.12mL |
|
Dissolving Methods |
in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:
|